Key Findings:  This study of triple-negative breast cancer cells found that two phytocannabinoids, cannabidiol and cannabichromene, and 2 caryophyllane sesquiterpenes, had anti-cancer activity against these cells and findings suggest that phytocannabinoids and terpenes may play a role in these anti-cancer effects and warrant further research.
Type of Study:  Laboratory Study
Study Result:  Positive
Study Location(s):  Italy
Year of Pub:  2022
Cannabinoids Studied:  Cannabichromene (CBC), Cannabidiol (CBD)
Phytocannabinoid Source:  Hemp derived
Chemotype:  Chemotype III
Terpenes Studied:  ß-Caryophyllene, Humulene
Receptors Studied:  CB1, CB2